Brian Morrissey is a Respiratory physician affiliated with University of California, Davis. OpenAlex indexes 65 publications with 1,141 citations (h-index 18).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
2221 Stockton Blvd
Sacramento, CA 958171418
Telephone
916-734-2011Registry record last updated 9 Jul 2007.
Industry payments
6 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Insmed, Inc.Program year202512 payments$17,829openpaymentsdata.cms.gov ↗
- VERTEX PHARMACEUTICALS INCORPORATEDProgram year20251 payment
- Insmed, Inc.Program year202425 payments$22,982openpaymentsdata.cms.gov ↗
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Respiratory
38.1%Other respiratory system products17.5%Trikafta100%Part D≥13 patientsbeta2-Adrenergic Agonist9.7%Albuterol Sulfate Hfa100%Part D≥14 patients+ 2 more classes in this area
Cancer & immunology
28.4%Kinase inhibitor18.9%Ofev100%Part D≥11 patientsPyridone9.5%Esbriet54%Pirfenidone46%Part D<11 patientsAnti-infectives
25.9%Macrolide Antimicrobial15%Azithromycin100%Part D≥16 patientsAminoglycoside Antibacterial3.7%Arikayce100%Part D<11 patients+ 2 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Playing With Thorns: A Case of Pulmonary Sporotrichosis
American Journal of Respiratory and Critical Care Medicine
2025 - The pharmacotherapeutic options in patients with catecholamine-resistant vasodilatory shock
Expert Review of Clinical Pharmacology
2022
Similar KOLs
Other experts from the same institution or the same specialty.
Ezra Amsterdam, MD
University of California, Davis
Michael Rogawski, MD
University of California, Davis
Christopher Bowlus, MD
University of California, Davis
Emanual Maverakis, MD
University of California, Davis
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”